Publications & Presentations


Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients with Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design

Liron Walsh, John F. Reilly, Caitlin Cornwall, Gregory A. Gaich, Debbie S. Gipson, Hiddo J.L. Heerspink, Leslie Johnson, Howard Trachtman, Katherine R. Tuttle, Youssef M.K. Farag, Krishna Padmanabhan, Xin-Ru Pan-Zhou, J.R. Woodworth, Frank S. Czerwiec

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model

Maolin Yu, Mark W. Ledeboer, Matthew Daniels, Goran Malojcic, Thomas T. Tibbitts, Marie Coeffet-Le Gal, Xin-Ru Pan-Zhou, Amy Westerling-Bui, Maria Beconi, John F. Reilly, Peter Mundel, and Jean-Christophe Harmange


Structural basis of TRPC4 regulation by calmodulin and pharmacological agents

Deivanayagabarathy Vinayagam, Dennis Quentin, Jing Yu-Strzelczyk, Oleg Sitsel, Felipe Merino, Markus Stabrin, Oliver Hofnagel, Maolin Yu, Mark W Ledeboer, Georg Nagel, Goran Malojcic, Stefan Raunser


Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis

Jonathan P. Troost, Howard Trachtman, Cathie Spino, Frederick J. Kaskel, Aaron Friedman, Marva M. Moxey-Mims, Richard N. Fine, Jennifer J. Gassman, Jeffrey B. Kopp, Liron Walsh, Rong Wang, Debbie S. Gipson


Generation of Collecting Duct Kidney Organoids from hiPSC

Sergii Kyrychenko, Xiang Pan, Eva Maria Fast, Alyssa B. Fanelli, Henrietta Bennet, Maria Lalioti, John F. Reilly, Peter Mundel, Amy Duyen Westerling-Bui

  • 2020 American Society of Nephrology Kidney Week
  • October 22-25, 2020
  • Virtual